Global Rare Disease Genetic Testing Market Size, Status and Forecast 2024-2031

Report ID: 919636 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Next-Generation Sequencing (NGS)
        1.2.3 Array Technology
        1.2.4 PCR-based Testing
        1.2.5 Fluorescence in Situ Hybridization (FISH)
        1.2.6 Sanger Sequencing
        1.2.7 Karyotyping
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Rare Disease Genetic Testing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Research Laboratories and CROs
        1.3.3 Diagnostic Laboratories
        1.3.4 Hospitals and Clinics
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Rare Disease Genetic Testing Market Perspective (2016-2027)
    2.2 Rare Disease Genetic Testing Growth Trends by Regions
        2.2.1 Rare Disease Genetic Testing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Rare Disease Genetic Testing Historic Market Share by Regions (2016-2021)
        2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Regions (2022-2027)
    2.3 Rare Disease Genetic Testing Industry Dynamic
        2.3.1 Rare Disease Genetic Testing Market Trends
        2.3.2 Rare Disease Genetic Testing Market Drivers
        2.3.3 Rare Disease Genetic Testing Market Challenges
        2.3.4 Rare Disease Genetic Testing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Rare Disease Genetic Testing Players by Revenue
        3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2016-2021)
        3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2016-2021)
    3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
    3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
        3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2020
    3.5 Rare Disease Genetic Testing Key Players Head office and Area Served
    3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
    3.7 Date of Enter into Rare Disease Genetic Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease Genetic Testing Breakdown Data by Type
    4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2016-2021)
    4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2022-2027)

5 Rare Disease Genetic Testing Breakdown Data by Application
    5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2016-2021)
    5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Rare Disease Genetic Testing Market Size (2016-2027)
    6.2 North America Rare Disease Genetic Testing Market Size by Type
        6.2.1 North America Rare Disease Genetic Testing Market Size by Type (2016-2021)
        6.2.2 North America Rare Disease Genetic Testing Market Size by Type (2022-2027)
        6.2.3 North America Rare Disease Genetic Testing Market Size by Type (2016-2027)
    6.3 North America Rare Disease Genetic Testing Market Size by Application
        6.3.1 North America Rare Disease Genetic Testing Market Size by Application (2016-2021)
        6.3.2 North America Rare Disease Genetic Testing Market Size by Application (2022-2027)
        6.3.3 North America Rare Disease Genetic Testing Market Size by Application (2016-2027)
    6.4 North America Rare Disease Genetic Testing Market Size by Country
        6.4.1 North America Rare Disease Genetic Testing Market Size by Country (2016-2021)
        6.4.2 North America Rare Disease Genetic Testing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Rare Disease Genetic Testing Market Size (2016-2027)
    7.2 Europe Rare Disease Genetic Testing Market Size by Type
        7.2.1 Europe Rare Disease Genetic Testing Market Size by Type (2016-2021)
        7.2.2 Europe Rare Disease Genetic Testing Market Size by Type (2022-2027)
        7.2.3 Europe Rare Disease Genetic Testing Market Size by Type (2016-2027)
    7.3 Europe Rare Disease Genetic Testing Market Size by Application
        7.3.1 Europe Rare Disease Genetic Testing Market Size by Application (2016-2021)
        7.3.2 Europe Rare Disease Genetic Testing Market Size by Application (2022-2027)
        7.3.3 Europe Rare Disease Genetic Testing Market Size by Application (2016-2027)
    7.4 Europe Rare Disease Genetic Testing Market Size by Country
        7.4.1 Europe Rare Disease Genetic Testing Market Size by Country (2016-2021)
        7.4.2 Europe Rare Disease Genetic Testing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Rare Disease Genetic Testing Market Size (2016-2027)
    8.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type
        8.2.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2016-2027)
    8.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Application
        8.3.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2016-2027)
    8.4 Asia-Pacific Rare Disease Genetic Testing Market Size by Region
        8.4.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Rare Disease Genetic Testing Market Size (2016-2027)
    9.2 Latin America Rare Disease Genetic Testing Market Size by Type
        9.2.1 Latin America Rare Disease Genetic Testing Market Size by Type (2016-2021)
        9.2.2 Latin America Rare Disease Genetic Testing Market Size by Type (2022-2027)
        9.2.3 Latin America Rare Disease Genetic Testing Market Size by Type (2016-2027)
    9.3 Latin America Rare Disease Genetic Testing Market Size by Application
        9.3.1 Latin America Rare Disease Genetic Testing Market Size by Application (2016-2021)
        9.3.2 Latin America Rare Disease Genetic Testing Market Size by Application (2022-2027)
        9.3.3 Latin America Rare Disease Genetic Testing Market Size by Application (2016-2027)
    9.4 Latin America Rare Disease Genetic Testing Market Size by Country
        9.4.1 Latin America Rare Disease Genetic Testing Market Size by Country (2016-2021)
        9.4.2 Latin America Rare Disease Genetic Testing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Rare Disease Genetic Testing Market Size (2016-2027)
    10.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type
        10.2.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2016-2027)
    10.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application
        10.3.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2016-2027)
    10.4 Middle East & Africa Rare Disease Genetic Testing Market Size by Country
        10.4.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Quest Diagnostics
        11.1.1 Quest Diagnostics Company Details
        11.1.2 Quest Diagnostics Business Overview
        11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
        11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.1.5 Quest Diagnostics Recent Development
    11.2 Centogene
        11.2.1 Centogene Company Details
        11.2.2 Centogene Business Overview
        11.2.3 Centogene Rare Disease Genetic Testing Introduction
        11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.2.5 Centogene Recent Development
    11.3 Invitae Corporation
        11.3.1 Invitae Corporation Company Details
        11.3.2 Invitae Corporation Business Overview
        11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
        11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.3.5 Invitae Corporation Recent Development
    11.4 3billion
        11.4.1 3billion Company Details
        11.4.2 3billion Business Overview
        11.4.3 3billion Rare Disease Genetic Testing Introduction
        11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.4.5 3billion Recent Development
    11.5 Arup Laboratories
        11.5.1 Arup Laboratories Company Details
        11.5.2 Arup Laboratories Business Overview
        11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
        11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.5.5 Arup Laboratories Recent Development
    11.6 Eurofins Scientific
        11.6.1 Eurofins Scientific Company Details
        11.6.2 Eurofins Scientific Business Overview
        11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
        11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.6.5 Eurofins Scientific Recent Development
    11.7 Strand Life Sciences
        11.7.1 Strand Life Sciences Company Details
        11.7.2 Strand Life Sciences Business Overview
        11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
        11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.7.5 Strand Life Sciences Recent Development
    11.8 Ambry Genetics
        11.8.1 Ambry Genetics Company Details
        11.8.2 Ambry Genetics Business Overview
        11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
        11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.8.5 Ambry Genetics Recent Development
    11.9 Perkin Elmer
        11.9.1 Perkin Elmer Company Details
        11.9.2 Perkin Elmer Business Overview
        11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
        11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.9.5 Perkin Elmer Recent Development
    11.10 Macrogen
        11.10.1 Macrogen Company Details
        11.10.2 Macrogen Business Overview
        11.10.3 Macrogen Rare Disease Genetic Testing Introduction
        11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.10.5 Macrogen Recent Development
    11.11 Baylor Genetics
        11.11.1 Baylor Genetics Company Details
        11.11.2 Baylor Genetics Business Overview
        11.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
        11.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.11.5 Baylor Genetics Recent Development
    11.12 Color Genomics
        11.12.1 Color Genomics Company Details
        11.12.2 Color Genomics Business Overview
        11.12.3 Color Genomics Rare Disease Genetic Testing Introduction
        11.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.12.5 Color Genomics Recent Development
    11.13 Preventiongenetics
        11.13.1 Preventiongenetics Company Details
        11.13.2 Preventiongenetics Business Overview
        11.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
        11.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.13.5 Preventiongenetics Recent Development
    11.14 Progenity
        11.14.1 Progenity Company Details
        11.14.2 Progenity Business Overview
        11.14.3 Progenity Rare Disease Genetic Testing Introduction
        11.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.14.5 Progenity Recent Development
    11.15 Coopersurgical
        11.15.1 Coopersurgical Company Details
        11.15.2 Coopersurgical Business Overview
        11.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
        11.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.15.5 Coopersurgical Recent Development
    11.16 Fulgent Genetics
        11.16.1 Fulgent Genetics Company Details
        11.16.2 Fulgent Genetics Business Overview
        11.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
        11.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.16.5 Fulgent Genetics Recent Development
    11.17 Myriad Genetics
        11.17.1 Myriad Genetics Company Details
        11.17.2 Myriad Genetics Business Overview
        11.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
        11.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.17.5 Myriad Genetics Recent Development
    11.18 LabCorp
        11.18.1 LabCorp Company Details
        11.18.2 LabCorp Business Overview
        11.18.3 LabCorp Rare Disease Genetic Testing Introduction
        11.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2016-2021)
        11.18.5 LabCorp Recent Development
    11.18 Opko Health
        .1 Opko Health Company Details
        .2 Opko Health Business Overview
        .3 Opko Health Rare Disease Genetic Testing Introduction
        .4 Opko Health Revenue in Rare Disease Genetic Testing Business (2016-2021)
        .5 Opko Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Next-Generation Sequencing (NGS)
    Table 3. Key Players of Array Technology
    Table 4. Key Players of PCR-based Testing
    Table 5. Key Players of Fluorescence in Situ Hybridization (FISH)
    Table 6. Key Players of Sanger Sequencing
    Table 7. Key Players of Karyotyping
    Table 8. Key Players of Others
    Table 9. Global Rare Disease Genetic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Rare Disease Genetic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Rare Disease Genetic Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Rare Disease Genetic Testing Market Share by Regions (2016-2021)
    Table 13. Global Rare Disease Genetic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Rare Disease Genetic Testing Market Share by Regions (2022-2027)
    Table 15. Rare Disease Genetic Testing Market Trends
    Table 16. Rare Disease Genetic Testing Market Drivers
    Table 17. Rare Disease Genetic Testing Market Challenges
    Table 18. Rare Disease Genetic Testing Market Restraints
    Table 19. Global Rare Disease Genetic Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Rare Disease Genetic Testing Market Share by Players (2016-2021)
    Table 21. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Genetic Testing as of 2020)
    Table 22. Ranking of Global Top Rare Disease Genetic Testing Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Rare Disease Genetic Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Rare Disease Genetic Testing Product Solution and Service
    Table 26. Date of Enter into Rare Disease Genetic Testing Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Rare Disease Genetic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Rare Disease Genetic Testing Revenue Market Share by Type (2016-2021)
    Table 30. Global Rare Disease Genetic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Rare Disease Genetic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Rare Disease Genetic Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Rare Disease Genetic Testing Revenue Market Share by Application (2016-2021)
    Table 34. Global Rare Disease Genetic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Rare Disease Genetic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Rare Disease Genetic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Rare Disease Genetic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Rare Disease Genetic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Rare Disease Genetic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Rare Disease Genetic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Rare Disease Genetic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Rare Disease Genetic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Rare Disease Genetic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Rare Disease Genetic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Rare Disease Genetic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Rare Disease Genetic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Rare Disease Genetic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Rare Disease Genetic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Rare Disease Genetic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Rare Disease Genetic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Rare Disease Genetic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Rare Disease Genetic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Rare Disease Genetic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Quest Diagnostics Company Details
    Table 67. Quest Diagnostics Business Overview
    Table 68. Quest Diagnostics Rare Disease Genetic Testing Product
    Table 69. Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 70. Quest Diagnostics Recent Development
    Table 71. Centogene Company Details
    Table 72. Centogene Business Overview
    Table 73. Centogene Rare Disease Genetic Testing Product
    Table 74. Centogene Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 75. Centogene Recent Development
    Table 76. Invitae Corporation Company Details
    Table 77. Invitae Corporation Business Overview
    Table 78. Invitae Corporation Rare Disease Genetic Testing Product
    Table 79. Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 80. Invitae Corporation Recent Development
    Table 81. 3billion Company Details
    Table 82. 3billion Business Overview
    Table 83. 3billion Rare Disease Genetic Testing Product
    Table 84. 3billion Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 85. 3billion Recent Development
    Table 86. Arup Laboratories Company Details
    Table 87. Arup Laboratories Business Overview
    Table 88. Arup Laboratories Rare Disease Genetic Testing Product
    Table 89. Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 90. Arup Laboratories Recent Development
    Table 91. Eurofins Scientific Company Details
    Table 92. Eurofins Scientific Business Overview
    Table 93. Eurofins Scientific Rare Disease Genetic Testing Product
    Table 94. Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 95. Eurofins Scientific Recent Development
    Table 96. Strand Life Sciences Company Details
    Table 97. Strand Life Sciences Business Overview
    Table 98. Strand Life Sciences Rare Disease Genetic Testing Product
    Table 99. Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 100. Strand Life Sciences Recent Development
    Table 101. Ambry Genetics Company Details
    Table 102. Ambry Genetics Business Overview
    Table 103. Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 104. Ambry Genetics Recent Development
    Table 105. Perkin Elmer Company Details
    Table 106. Perkin Elmer Business Overview
    Table 107. Perkin Elmer Rare Disease Genetic Testing Product
    Table 108. Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 109. Perkin Elmer Recent Development
    Table 110. Macrogen Company Details
    Table 111. Macrogen Business Overview
    Table 112. Macrogen Rare Disease Genetic Testing Product
    Table 113. Macrogen Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 114. Macrogen Recent Development
    Table 115. Baylor Genetics Company Details
    Table 116. Baylor Genetics Business Overview
    Table 117. Baylor Genetics Rare Disease Genetic Testing Product
    Table 118. Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 119. Baylor Genetics Recent Development
    Table 120. Color Genomics Company Details
    Table 121. Color Genomics Business Overview
    Table 122. Color Genomics Rare Disease Genetic Testing Product
    Table 123. Color Genomics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 124. Color Genomics Recent Development
    Table 125. Preventiongenetics Company Details
    Table 126. Preventiongenetics Business Overview
    Table 127. Preventiongenetics Rare Disease Genetic Testing Product
    Table 128. Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 129. Preventiongenetics Recent Development
    Table 130. Progenity Company Details
    Table 131. Progenity Business Overview
    Table 132. Progenity Rare Disease Genetic Testing Product
    Table 133. Progenity Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 134. Progenity Recent Development
    Table 135. Coopersurgical Company Details
    Table 136. Coopersurgical Business Overview
    Table 137. Coopersurgical Rare Disease Genetic Testing Product
    Table 138. Coopersurgical Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 139. Coopersurgical Recent Development
    Table 140. Fulgent Genetics Company Details
    Table 141. Fulgent Genetics Business Overview
    Table 142. Fulgent Genetics Rare Disease Genetic Testing Product
    Table 143. Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 144. Fulgent Genetics Recent Development
    Table 145. Myriad Genetics Company Details
    Table 146. Myriad Genetics Business Overview
    Table 147. Myriad Genetics Rare Disease Genetic Testing Product
    Table 148. Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 149. Myriad Genetics Recent Development
    Table 150. LabCorp Company Details
    Table 151. LabCorp Business Overview
    Table 152. LabCorp Rare Disease Genetic Testing Product
    Table 153. LabCorp Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 154. LabCorp Recent Development
    Table 155. Opko Health Company Details
    Table 156. Opko Health Business Overview
    Table 157. Opko Health Rare Disease Genetic Testing Product
    Table 158. Opko Health Revenue in Rare Disease Genetic Testing Business (2016-2021) & (US$ Million)
    Table 159. Opko Health Recent Development
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rare Disease Genetic Testing Market Share by Type: 2020 VS 2027
    Figure 2. Next-Generation Sequencing (NGS) Features
    Figure 3. Array Technology Features
    Figure 4. PCR-based Testing Features
    Figure 5. Fluorescence in Situ Hybridization (FISH) Features
    Figure 6. Sanger Sequencing Features
    Figure 7. Karyotyping Features
    Figure 8. Others Features
    Figure 9. Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2027
    Figure 10. Research Laboratories and CROs Case Studies
    Figure 11. Diagnostic Laboratories Case Studies
    Figure 12. Hospitals and Clinics Case Studies
    Figure 13. Others Case Studies
    Figure 14. Rare Disease Genetic Testing Report Years Considered
    Figure 15. Global Rare Disease Genetic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Rare Disease Genetic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Rare Disease Genetic Testing Market Share by Regions: 2020 VS 2027
    Figure 18. Global Rare Disease Genetic Testing Market Share by Regions (2022-2027)
    Figure 19. Global Rare Disease Genetic Testing Market Share by Players in 2020
    Figure 20. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Genetic Testing as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Rare Disease Genetic Testing Revenue in 2020
    Figure 22. Global Rare Disease Genetic Testing Revenue Market Share by Type (2016-2021)
    Figure 23. Global Rare Disease Genetic Testing Revenue Market Share by Type (2022-2027)
    Figure 24. North America Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Rare Disease Genetic Testing Market Share by Type (2016-2027)
    Figure 26. North America Rare Disease Genetic Testing Market Share by Application (2016-2027)
    Figure 27. North America Rare Disease Genetic Testing Market Share by Country (2016-2027)
    Figure 28. United States Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Rare Disease Genetic Testing Market Share by Type (2016-2027)
    Figure 32. Europe Rare Disease Genetic Testing Market Share by Application (2016-2027)
    Figure 33. Europe Rare Disease Genetic Testing Market Share by Country (2016-2027)
    Figure 34. Germany Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Rare Disease Genetic Testing Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Rare Disease Genetic Testing Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Rare Disease Genetic Testing Market Share by Region (2016-2027)
    Figure 44. China Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Rare Disease Genetic Testing Market Share by Type (2016-2027)
    Figure 52. Latin America Rare Disease Genetic Testing Market Share by Application (2016-2027)
    Figure 53. Latin America Rare Disease Genetic Testing Market Share by Country (2016-2027)
    Figure 54. Mexico Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Rare Disease Genetic Testing Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Rare Disease Genetic Testing Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Rare Disease Genetic Testing Market Share by Country (2016-2027)
    Figure 60. Turkey Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Rare Disease Genetic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Quest Diagnostics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 64. Centogene Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 65. Invitae Corporation Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 66. 3billion Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 67. Arup Laboratories Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 68. Eurofins Scientific Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 69. Strand Life Sciences Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 70. Ambry Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 71. Perkin Elmer Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 72. Macrogen Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 73. Baylor Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 74. Color Genomics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 75. Preventiongenetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 76. Progenity Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 77. Coopersurgical Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 78. Fulgent Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 79. Myriad Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 80. LabCorp Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 81. Opko Health Revenue Growth Rate in Rare Disease Genetic Testing Business (2016-2021)
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Quest Diagnostics
Centogene
Invitae Corporation
3billion
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer
Macrogen
Baylor Genetics
Color Genomics
Preventiongenetics
Progenity
Coopersurgical
Fulgent Genetics
Myriad Genetics
LabCorp
Opko Health
Frequently Asked Questions
Rare Disease Genetic Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rare Disease Genetic Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rare Disease Genetic Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Trauma Care Center

A trauma center (or trauma centre) is a hospital equipped and staffed to provide care for patient ... Read More